RG-HRV16: Clinical Trials

2 trials of RG-HRV16, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 withdrawn. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Withdrawn 1

Follow RG-HRV16: new trials by email Literature Review of RG-HRV16 trials Research Report on RG-HRV16

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Airway Inflammatory Responses to Experimental Rhinovirus Infection
RG-HRV16 - Healthy Volunteers, Rhinovirus
Phase 1WithdrawnUniversity of North Carolina, Chapel Hill2024-12-012025-06-03
A First-in-Human Safety and Dose-Finding Study of New Type-16 Human Rhinovirus (RG-HRV16) Inoculum in Healthy Volunteers
RG-HRV16, Placebo - Healthy Volunteers
Phase 1CompletedUniversity of Wisconsin, Madison362013-07-012019-06-03

Sponsors

University of North Carolina, Chapel Hill (1)  ·  University of Wisconsin, Madison (1)

Countries

United States (2)

Top investigators

James Gern, MD (1)  ·  Michelle Hernandez, MD (1)